Home
Contact
Site Index
About Us
Management
Board of Directors
Corporate Overview
Public Policy
Commitment to Safety
Vision/Mission
Pipeline
Follow-On Biologics
INS-19
INS-20
INS-21
INS-22
Proprietary Protein Platform
IPLEX
Oncology Programs
Science/Technology
People
Capabilities
Facilities
Technologies
Newsroom
Press Releases
Latest Developments
Media Inquiries
News Subscription
Event Calendar
Investors
Stock Info
Corporate Governance
SEC Filings
Analysts
Stock History
Email Alerts
Investor Relations
Careers
Products
Iplex™
Press Releases
Jun. 20, 2008
Insmed to Request Hearing Before NASDAQ Panel to Review NASDAQ Staff Determination
Read More
May. 8, 2008
Insmed Announces First Quarter 2008 Financial Results
Read More